498 results
SD
EX-1.01
BAX
Baxter International Inc.
31 May 24
Conflict minerals disclosure
8:10am
Securities Litigation Reform Act of 1995, concerning the Company’s conflict mineral policies and related activities. These forward-looking statements provide … recalls, withdrawals, launch delays, warning letters, import bans, sanctions, seizures, litigation, or declining sales, including the focus on evaluating
S-8
EX-3.1
BAX
Baxter International Inc.
7 May 24
Registration of securities for employees
4:31pm
, the commencement, prosecution, or defense of any litigation, and the seeking of injunctive relief in such litigation).
I. Board-Solicited Stockholder Action
8-K
EX-99.1
BAX
Baxter International Inc.
2 May 24
Baxter Reports First-quarter 2024 Results
7:17am
, withdrawals, launch delays, warning letters, import bans, sanctions, seizures, litigation or declining sales, including the focus on evaluating product … , taxation and rebate policies; the outcome of pending or future litigation; the impact of competitive products and pricing, including generic competition
8-K
EX-10.3
1v9bg0
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
8-K
h3ynp9
4 Mar 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
2tmf f5b7tq2x
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
EX-99.1
t2dis 5yc3
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
4i38nepz6y3
2 Oct 23
Completion of Acquisition or Disposition of Assets
9:02am
8-K
EX-99.1
umwy38glyh83n8lsglgz
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
vsqg03jy
6 Jul 23
Regulation FD Disclosure
8:30am
SD
EX-1.01
d93bvudij45 gmu9jhnf
31 May 23
Conflict minerals disclosure
4:36pm
8-K
EX-2.1
iu1wpe9e14euvd0
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am